Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.19
+0.47 (4.38%)
Nov 4, 2024, 4:00 PM EST - Market closed
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 43 employees as of December 31, 2021. The number of employees increased by 21 or 95.45% compared to the previous year.
Employees
43
Change (1Y)
21
Growth (1Y)
95.45%
Revenue / Employee
$680,372
Profits / Employee
-$756,395
Market Cap
271.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accolade | 2,400 |
| Sight Sciences | 214 |
| Codexis | 174 |
| TScan Therapeutics | 154 |
| Rigel Pharmaceuticals | 147 |
| Acrivon Therapeutics | 61 |
| Lexeo Therapeutics | 58 |
| Sera Prognostics | 57 |
ARTV News
- 13 days ago - Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors - GlobeNewsWire
- 7 weeks ago - Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch - Benzinga
- 3 months ago - Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data - Seeking Alpha
- 3 months ago - U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week - Seeking Alpha
- 3 months ago - Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering - GlobeNewsWire
- 4 months ago - Autoimmune biotech Artiva Biotherapeutics refiles for a $100 million IPO, following attempt in 2021 - Renaissance Capital